Escape of pathogens from the host immune response by mutations and mimicry. Possible means to improve vaccine performance

被引:4
作者
Berger, Gerard
机构
[1] 14 Impasse des Carpeaux, Perigny-sur-Yerres
关键词
HEPATITIS-C VIRUS; SMOOTH-MUSCLE ANTIBODIES; MYELIN BASIC-PROTEIN; MOLECULAR MIMICRY; CROSS-REACTIVITY; MEASLES-VIRUS; B VACCINATION; INFLUENZA-A; T-CELL; CHEMOKINE RECEPTORS;
D O I
10.1016/j.mehy.2015.08.010
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The ability of certain pathogens, such as human immunodeficiency, hepatitis C, herpes simplex, influenza viruses, Plasmodium falciparum, etc., to escape from host immune response is generally ascribed to high mutation rate of their genome. We challenge this assumption and propose that molecular mimicry of host antigens by these pathogens could also participate to this resistance. Several studies show that there is no correlation between the mutation rate value of a pathogen and the possibility to develop an effective vaccine. On the other hand, pathogens which do not respond to vaccine are usually reported to display host protein mimicry. We propose to suppress in the thymus the epitopes of the self which are in common with the pathogen. This could be achieved by intrathymic injection of antibodies against this microorganism. These antibodies would be obtained by vaccination of a foreign animal species. It is expected that the negative selection of the CD4(+) and CD8(+) T lymphocytes specific for these epitopes would be prevented, that the number of epitopes recognized as foreign to the host would be increased and that the immune response diversity would be enhanced. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:664 / 669
页数:6
相关论文
共 93 条
[1]  
Abu-Shakra M, 1991, Immunol Ser, V55, P285
[2]   CHEMOKINE RECEPTORS AND MOLECULAR MIMICRY [J].
AHUJA, SK ;
GAO, JL ;
MURPHY, PM .
IMMUNOLOGY TODAY, 1994, 15 (06) :281-287
[3]   Sequence evolution and escape from specific immune pressure of an HIV-1 Rev epitope with extensive sequence similarity to human nucleolar protein 6 [J].
Allard, S. D. ;
de Goede, A. L. ;
De Keersmaecker, B. ;
Heirman, C. ;
Lacor, P. ;
Osterhaus, A. D. M. E. ;
Demanet, C. ;
Thielemans, K. ;
Gruters, R. A. ;
Aerts, J. L. .
TISSUE ANTIGENS, 2012, 79 (03) :174-185
[4]   Hepatitis B vaccination and the risk of multiple sclerosis [J].
Ascherio, A ;
Zhang, SM ;
Hernán, MA ;
Olek, MJ ;
Coplan, PM ;
Brodovicz, K ;
Walker, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) :327-332
[5]   No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine [J].
Belloni, C ;
Avanzini, MA ;
De Silvestri, A ;
Martinetti, M ;
Pasi, A ;
Coslovich, E ;
Autelli, M ;
Masanti, ML ;
Cuccia, M ;
Tinelli, C ;
Rondini, G ;
Lorini, R .
PEDIATRICS, 2002, 110 (01) :e4
[7]   Hepatitis A vaccine associated with autoimmune hepatitis [J].
Berry, P. A. ;
Smith-Laing, G. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (15) :2238-2239
[8]   Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura [J].
Bettaieb, A ;
Oksenhendler, E ;
Duedari, N ;
Bierling, P .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (01) :19-23
[9]  
Bianchi Francesco B, 2007, Dig Liver Dis, V39 Suppl 1, pS22
[10]   MOLECULAR MIMICRY IN THE PATHOGENESIS OF AIDS - THE HIV MHC MYCOPLASMA TRIANGLE [J].
BISSET, LR .
MEDICAL HYPOTHESES, 1994, 43 (06) :388-396